Overview

A Bioequivalence Study of Tobradex AF

Status:
Completed

Trial end date:
2006-08-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.

Phase:

Phase 3

Details

Lead Sponsor:

Alcon Research

Treatments:

BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Tobramycin
Tobramycin, Dexamethasone Drug Combination